Novo Nordisk’s experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The New England Journal of Medicine on Wednesday, which is comparable to previous trial results of injectable Wegovy.
Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version
Popular Categories
Previous article![]( "Regeneron’s rare bone disorder drug succeeds in late-stage trial")
Next article![]( "Health Rounds: Laser surgery safe for nearsighted teens, study shows")
